Cooper Companies (COO) Cash from Investing Activities (2009 - 2026)

Cooper Companies' (COO) quarterly Cash from Investing Activities came in at -$90.0 million in Q2 2026, down 13.64% year-on-year from -$104.2 million in Q2 2025, and up 12.54% quarter-over-quarter from -$102.9 million in Q1 2026.

Cooper Companies (COO) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Cooper Companies' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$90.0 million for Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 13.64% year-over-year to -$90.0 million in Q2 2026; TTM through Apr 2026 was -$389.8 million, a 28.04% increase from a year earlier, with the FY2025 full-year figure at -$372.9 million, up 51.23% from the prior year.
  • Cash from Investing Activities grew to -$90.0 million in Q2 2026 per COO's latest filing, from -$102.9 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$15.7 million in Q2 2022 and bottomed at -$1.7 billion in Q1 2022.
  • The 5-year median for Cash from Investing Activities is -$98.4 million (2025), against an average of -$200.6 million.
  • Across the five-year window, Cash from Investing Activities tumbled 1130.14% in 2022 and surged 93.21% in 2023, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$99.7 million in 2022, then tumbled by 61.28% to -$160.8 million in 2023, then plunged by 50.25% to -$241.6 million in 2024, then surged by 59.11% to -$98.8 million in 2025, then gained by 8.91% to -$90.0 million in 2026.
  • Per Business Quant, the three latest COO Cash from Investing Activities figures stand at -$90.0 million (Q2 2026), -$102.9 million (Q1 2026), and -$98.8 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 125.97 Bn 120.75 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.74 Bn 43.93 Bn 2.15 Bn -139.00 Mn
3 Alcon 32.94 Bn 31.28 Bn 1.53 Bn -218.00 Mn
4 Medline 32.85 Bn 30.61 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.46 Bn 27.80 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.60 Bn 23.16 Bn 329.20 Mn -43.20 Mn
7 Solventum 13.99 Bn 13.43 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.76 Bn 13.62 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.06 Bn 11.00 Bn 736.59 Mn -131.58 Mn
10 Baxter International 11.94 Bn 9.93 Bn 891.00 Mn -133.00 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -90.00 Mn
Apr 30, 2026 -90.00 Mn
Jan 31, 2026 -102.90 Mn
Jan 31, 2026 -102.90 Mn
Oct 31, 2025 -98.80 Mn
Oct 31, 2025 -98.80 Mn
Jul 31, 2025 -98.10 Mn
Jul 31, 2025 -98.10 Mn
Apr 30, 2025 -79.20 Mn
Apr 30, 2025 -79.20 Mn
Jan 31, 2025 -96.80 Mn
Jan 31, 2025 -96.80 Mn
Oct 31, 2024 -241.60 Mn
Oct 31, 2024 -241.60 Mn
Jul 31, 2024 -124.10 Mn
Jul 31, 2024 -124.10 Mn
Apr 30, 2024 -74.80 Mn
Apr 30, 2024 -74.80 Mn
Jan 31, 2024 -324.10 Mn
Jan 31, 2024 -324.10 Mn